Shufeng Jiedu capsule for acute exacerbation of chronic obstructive pulmonary disease: a protocol of multicentre, randomised, double-blind, placebo-controlled trial

Shufeng Jiedu capsule for acute exacerbation of chronic obstructive pulmonary disease: a protocol of multicentre, randomised, double-blind, placebo-controlled trial

Introduction Chronic obstructive pulmonary disease (COPD) represents one of the leading causes of death worldwide. Published clinical trials suggest that the Chinese patent herbal medicine Shufeng Jiedu capsule (SFJD) is safe and may be effective for treating acute exacerbations of COPD (AECOPD). Ho...

Full description

Bibliographic Details
Main Authors:	Michael Moore, Ruyu Xia, Xiaoyang Hu, Merlin Willcox, Jianping Liu, Yutong Fei, Nick Francis, Mengyuan Dai, Lishan Zhang, Zhijun Jie, Xiaoyun Fan, Changhao Liang, Guanghe Fei
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-09-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/13/9/e070864.full

Similar Items

Study on basic and clinical application of Shufeng Jiedu Capsule in treating respiratory tract infection
by: Yanqi Han, et al.
Published: (2023-04-01)

The add-on effect of Shufeng Jiedu capsule for treating COVID-19: A systematic review and meta-analysis
by: Xiaodi Sheng, et al.
Published: (2022-10-01)

Efficacy and Safety of Shufeng Jiedu Capsules in the Adjuvant Treatment of Community-acquired Pneumonia in Adult: a Meta-analysis
by: Jiang YANG, Xuanlin LI, Jianxin WANG, Yang XIE, Huiguo LIU, Suyun LI, Minghang WANG
Published: (2022-08-01)

Literature Characteristics and Outcome Measures of Randomized Controlled Trials of Oral Traditional Chinese Medicine in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
by: WANG Jing, WANG Hui, SONG Shiqun, JI Guanghe, GUO Yakun, YAO Danning, ZHAO Shuhan, LI Duoduo, XIA Ruyu, ZHANG Lishan
Published: (2024-01-01)

Anti-tumor effect of Huayu Jiedu formula on SGC-7901 cancer cell
by: Wei Zheng, et al.
Published: (2016-02-01)

Therapeutic effects of Huayu Jiedu formula on endometriosis via downregulating GATA 6 expression
by: Wen Cheng, et al.
Published: (2024-01-01)

Qingfei Jiedu Granules fight influenza by regulating inflammation, immunity, metabolism, and gut microbiota
by: Xuran Cui, et al.
Published: (2023-03-01)

Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma
by: Yuqing Xie, et al.
Published: (2023-02-01)

Wenzi Jiedu Recipe ameliorates colorectal cancer by remodeling the gut microbiota and tumor microenvironment
by: Wenli Qiu, et al.
Published: (2022-09-01)

Effect of YangxueJiedu Decoction on the expression levels of IL-36 in psoriasis-like lesions in mice
by: Qi ZHANG, et al.
Published: (2021-06-01)

Molecular mechanisms of Huanglian jiedu decoction on ulcerative colitis based on network pharmacology and molecular docking
by: Jing Yang, et al.
Published: (2022-04-01)

Integrated gut microbiota and metabolome analysis reveals the mechanism of Xiaoai Jiedu recipe in ameliorating colorectal cancer
by: Wenli Qiu, et al.
Published: (2023-06-01)

New strategies for identifying and masking the bitter taste in traditional herbal medicines: The example of Huanglian Jiedu Decoction
by: Xiumei Ke, et al.
Published: (2022-08-01)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
by: Shrimanker, R, et al.
Published: (2017)

Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying bronchodilators in preventing exacerbations of bronchiectasis
by: John R Hurst, et al.
Published: (2023-08-01)

Treating Acute EXacerbations of COPD with Chinese HerbAL MedIcine to aid AntiBiotic Use Reduction (EXCALIBUR): study protocol of a randomised double-blind, placebo-controlled feasibility trial
by: Xiao-Yang Hu, et al.
Published: (2022-12-01)

Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial
by: Merlin L. Willcox, et al.
Published: (2023-09-01)

Potential Targets and Mechanisms of Jiedu Quyu Ziyin Decoction for Treating SLE-GIOP: Based on Network Pharmacology and Molecular Docking
by: Jie Li, et al.
Published: (2023-01-01)

In vitro and in vivo antiviral effect of Fufang Yinhua Jiedu granules (FFYH) combined with oseltamivir against influenza A virus
by: Zhihui Zheng, et al.
Published: (2023-02-01)

Prevention of COPD exacerbation by lysozyme: a double-blind, randomized, placebo-controlled study
by: Fukuchi Y, et al.
Published: (2016-04-01)

Mechanism of Gynecological Tiaoqi Jiedu Formula in Treatment of Endometritis with Dampness and Heat: A Prospective Laboratory-Based Mice Model Study
by: Jixiang Chen, et al.
Published: (2023-12-01)

Gongying-Jiedu-Xiji recipe promotes the healing of venous ulcers by inhibiting ferroptosis via the CoQ-FSP1 axis
by: Yongpan Lu, et al.
Published: (2023-12-01)

Exploring the pharmacological mechanism of Xianlian Jiedu decoction in the treatment of colorectal Cancer based on network pharmacology, molecular docking and experimental validation
by: Ke Cai, et al.
Published: (2023-12-01)

Molecular mechanisms of Huanglian Jiedu decoction in treating Alzheimer’s disease by regulating microbiome via network pharmacology and molecular docking analysis
by: Renyuan Zheng, et al.
Published: (2023-03-01)

Study on the function of Huazhuo Jiedu Decoction in promoting the homing of bone marrow mesenchymal stem cells and contributing to the treatment of ulcerative colitis
by: Yumei Ma, et al.
Published: (2023-08-01)

Screening of the active Ingredients in Huanglian Jiedu decoction through amide bond-Immobilized magnetic nanoparticle-assisted cell membrane chromatography
by: Fengyun Liao, et al.
Published: (2022-12-01)

Jiedu Yizhi Formula Improves Cognitive Function by Regulating the Gut Dysbiosis and TLR4/NF-κB Signaling Pathway
by: Zhang P, et al.
Published: (2023-01-01)

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
by: Pavord, I, et al.
Published: (2012)

Randomised Double-blind Placebo-Controlled Multicentre Trial for the Effects of Yokukansan in Smokers with Depressive Tendencies
by: Maki Komiyama, et al.
Published: (2023-04-01)

Multicentre Double-Blind Placebo-Controlled Food Challenge Study in Children Sensitised to Cashew Nut.
by: Johanna P M van der Valk, et al.
Published: (2016-01-01)

Suprascapular nerve block for the treatment of adhesive capsulitis: a randomised double-blind placebo-controlled trial
by: Tiffany K Gill, et al.
Published: (2022-11-01)

Effects of YuPingFeng granules on acute exacerbations of COPD: a randomized, placebo-controlled study
by: Ma JF, et al.
Published: (2018-10-01)

Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: A placebo-controlled double-blind trial
by: Schacher Christian, et al.
Published: (2009-07-01)

Jianpi Jiedu decoction reverses 5-fluorouracil resistance in colorectal cancer by suppressing the xCT/GSH/GPX4 axis to induce ferroptosis
by: Qin-ling Ou, et al.
Published: (2024-03-01)

Jiedu Fuzheng decoction improves the proliferation, migration, invasion and EMT of non-small cell lung cancer via the Wnt/β-catenin pathway
by: Fang Fang, et al.
Published: (2023-12-01)

Uncovering the active constituents and mechanisms of Rujin Jiedu powder for ameliorating LPS-induced acute lung injury using network pharmacology and experimental investigations
by: Yuhui Ma, et al.
Published: (2023-05-01)

Evaluation of LiangXue JieDu Therapy in Combination With Western Medicine for Acute-On-Chronic Liver Failure: A Systematic Review and meta-Analysis
by: Ke Shi, et al.
Published: (2022-07-01)

Qingfei Jiedu decoction inhibits PD-L1 expression in lung adenocarcinoma based on network pharmacology analysis, molecular docking and experimental verification
by: Junjie Pan, et al.
Published: (2022-08-01)

Impact of corticosteroids on the duration of ventilatory support during severe acute exacerbations of chronic obstructive pulmonary disease in patients in the intensive care unit: a study protocol for a multicentre, randomized, placebo-controlled, double-blind trial
by: Alexis Ferré, et al.
Published: (2023-03-01)

Theobromine for the treatment of persistent cough: a randomised, multicentre, double-blind, placebo-controlled clinical trial
by: Morice, A, et al.
Published: (2017)